Developing Guidelines Before, During, and After the COVID-19 Pandemic
- PMID: 32931327
- PMCID: PMC7505021
- DOI: 10.7326/M20-4907
Developing Guidelines Before, During, and After the COVID-19 Pandemic
Abstract
These authors discuss several challenges and solutions for developers of COVID-19–related guidelines and recommendations.
Conflict of interest statement
Figures
References
-
- Qaseem A, Forland F, Macbeth F, et al; Board of Trustees of the Guidelines International Network. Guidelines International Network: toward international standards for clinical practice guidelines. Ann Intern Med. 2012;156:525-31. [PMID: 22473437] doi:10.7326/0003-4819-156-7-201204030-00009 - PubMed
-
- Graham R, Mancher M, Wolman DM, et al, eds; Committee on Standards for Developing Trustworthy Clinical Practice Guidelines; Institute of Medicine. Clinical Practice Guidelines We Can Trust. National Academies Pr; 2011. - PubMed
-
- Vandvik PO, Brandt L. Future of evidence ecosystem series: evidence ecosystems and learning health systems: why bother? J Clin Epidemiol. 2020;123:166-170. [PMID: 32145365] doi:10.1016/j.jclinepi.2020.02.008 - PubMed
-
- Glasziou PP, Sanders S, Hoffmann T. Waste in covid-19 research [Editorial]. BMJ. 2020;369:m1847. [PMID: 32398241] doi:10.1136/bmj.m1847 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical